Make your money go further for just 25p per day

PREMIUM

Mega-Trends Portfolio: CRISPR is the future

17/03/2021

Trends US

CRISPR image

We have covered CRISPR/Cas9 before and hailed it as one of the most important inventions of the century. Several significant recent developments suggest that this revolutionary new technology is about to start realising its potential, which could clearly be significant for investors and constituents of our high-performing Mega Trends portfolio which rose 76% in 2020. Find out more in our update here.


CRISPR/Cas9 enables the editing of DNA; that’s all. It means we can edit the fundamental building blocks of nature that make us who we are. It also has the potential to wipe out certain diseases, radically improve crop yields, but a certain Vladimir Vladimirovich Putin once argued that genetic engineering “may be more terrifying than a nuclear bomb.”

If the concept of gene editing scares…

Continue reading our content…

Gain access to all our excellent content for just £90 per year, that’s just 25p per day for financial freedom.
  • Unlimited access to our market-beating portfolios
  • In-depth coverage of many of the world’s great companies
  • Unique insights from our top research team
Register FREE for access to limited content.
  • Company and markets insights
  • Sponsored content
  • Podcasts

Previous article Next article

Have your say

Log in or register to view or add comments.

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on bluebird bio

Mega-Trends Portfolio: CRISPR is the future

17/03/2021 · Portfolio

We have covered CRISPR/Cas9 before and hailed it as one of the most important inventions of…


More on CRISPR Therapeutics

An immense opportunity

30/08/2022 · Portfolio

CRISPR Therapeutics’ therapy for sickle cell disease could be available next year; this is incredibly exciting…


Mega-Trends: A troubling 2021 opens opportunities for recovery

11/02/2022 · Portfolio

Sign-up to our free email updates

SIGN UP